Diabetes Clinical Trials in New York

Showing 501-520 of 679 trials

Glucose Meter Study

NCT00782496

The purpose of this study is to evaluate if the meal marker and reminder feature of the Contour meter along with education maintains or increases frequency of testing blood sugar after meals and enables behavioral changes that may lead to improvement in glycemic control.

Diabetes Mellitus

Ascensia Diabetes Care211 participantsStarted Nov 2008

Atlanta, Georgia, United States • Minneapolis, Minnesota, United States • New York, New York, United States +1 more locations

UNKNOWNNA< 1 mile

Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss

NCT02621008

A self administered 16 weeks plus follow up study to explore the efficacy of mobile phone driven apps for stress reduction coupled with guidance for healthy living among obese and overweight populations. The Study primary end points are weight of the participants, as well as glucose measurements (for subject with diabetes) and blood pressure (of subjects with hypertension).

DiabetesHypertensionPre-diabetes+4 more

Eco Fusion500 participantsStarted Nov 2015

New York, New York, United States

COMPLETEDNA< 1 mile

Mobile Insulin Titration Intervention

NCT01879579

The purpose of this pilot study is to determine whether text message (and phone) communication can be effectively utilized to adjust long-acting insulin, compared to standard practice.

Diabetes Mellitus

NYU Langone Health61 participantsStarted Jun 2013

New York, New York, United States

Glucose Meter Study

Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss

Mobile Insulin Titration Intervention

Diabetes Trials in Other Cities

Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

Performance of an Investigational Blood Glucose Monitoring System

Study of an Investigational Glucose Meter System

Evaluation of the A1CNow+ Test Kit

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants

An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Other Conditions in New York